June 30 (Reuters) - Traws Pharma Inc TRAW.O:
TRAWS PHARMA ADVANCES ANTIVIRAL PIPELINE WITH MULTIPLE REGULATORY SUBMISSIONS
TRAWS PHARMA INC - BRIEFING DOCUMENTS SUBMITTED TO FDA FOR TXM ACCELERATED APPROVAL
TRAWS PHARMA INC - SEPARATE ARM TO EVALUATE TXM FOR H5N1 BIRD FLU
Source text: ID:nGNX8fBYjP
Further company coverage: TRAW.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.